Literature DB >> 27605746

Effect of Copper on l-Cysteine/l-Cystine Influx in Normal Human Erythrocytes and Erythrocytes of Wilson's Disease.

Nabarun Mandal1, Debojyoti Bhattacharjee2, Jayanta Kumar Rout3, Anindya Dasgupta4, Gorachand Bhattacharya5, Chandan Sarkar3, Prasanta Kumar Gangopadhyaya6.   

Abstract

Wilson's disease is a disease of abnormal copper metabolism in which free serum copper level is raised. The objective of the study was to determine, whether in Wilson disease, l-cysteine/l-cystine influx into RBC was decreased or not and the specific amino acid transporter affected by copper in normal human RBC. For l-cysteine/l-cystine influx, ten untreated cases, ten treated cases and ten age and sex matched healthy controls were recruited. To study the effect of copper on l-cysteine/l-cystine influx in RBC, 15 healthy subjects were selected. RBC GSH and l-cysteine/l-cystine influx were estimated by Beautler's and Yildiz's method respectively. In untreated cases, l-cysteine/l-cystine influx and erythrocyte GSH level were decreased showing that elevated level of free copper in serum or media decreased l-cysteine/l-cystine influx in human RBC. Copper treatment inhibited L amino acid transporter in normal RBC specifically.

Entities:  

Keywords:  Human erythrocyte; Reduced glutathione; Wilson’s disease; l-Cysteine/l-cystine influx

Year:  2016        PMID: 27605746      PMCID: PMC4992493          DOI: 10.1007/s12291-016-0555-z

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  21 in total

1.  Thiols as a measure of plasma redox status in healthy subjects and in patients with renal or liver failure.

Authors:  A Andersson; A Lindgren; M Arnadottir; H Prytz; B Hultberg
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

2.  Improved method for the determination of blood glutathione.

Authors:  E BEUTLER; O DURON; B M KELLY
Journal:  J Lab Clin Med       Date:  1963-05

Review 3.  Molecular biology of mammalian plasma membrane amino acid transporters.

Authors:  M Palacín; R Estévez; J Bertran; A Zorzano
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

4.  Sensitive, direct colorimetric assay for copper in serum.

Authors:  A Abe; S Yamashita; A Noma
Journal:  Clin Chem       Date:  1989-04       Impact factor: 8.327

5.  Mapping, cloning and genetic characterization of the region containing the Wilson disease gene.

Authors:  K Petrukhin; S G Fischer; M Pirastu; R E Tanzi; I Chernov; M Devoto; L M Brzustowicz; E Cayanis; E Vitale; J J Russo
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

6.  Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins.

Authors:  E I Closs; C R Lyons; C Kelly; J M Cunningham
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

7.  Wilson disease: clinical presentation, treatment, and survival.

Authors:  W Stremmel; K W Meyerrose; C Niederau; H Hefter; G Kreuzpaintner; G Strohmeyer
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

8.  L-cysteine influx in erythrocytes as a function of human age.

Authors:  Syed Ibrahim Rizvi; Pawan Kumar Maurya
Journal:  Rejuvenation Res       Date:  2008-06       Impact factor: 4.663

9.  Hemolytic anemia in Wilson disease: clinical findings and biochemical mechanisms.

Authors:  S J Forman; K S Kumar; A G Redeker; P Hochstein
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

10.  The Wilson disease gene: spectrum of mutations and their consequences.

Authors:  G R Thomas; J R Forbes; E A Roberts; J M Walshe; D W Cox
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

View more
  1 in total

1.  Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature.

Authors:  Gaurav V Sarode; Kyoungmi Kim; Dorothy A Kieffer; Noreene M Shibata; Tomas Litwin; Anna Czlonkowska; Valentina Medici
Journal:  Metabolomics       Date:  2019-03-12       Impact factor: 4.290

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.